Solutions

By phase — BA-BE through IV

From bioequivalence studies and first-in-human dose escalation to long-running post-marketing surveillance.

BA-BE: pre-built templates, replicate-design support, intensive PK sampling.

Phase II/III: multi-site scale, RBQM, and central monitoring.

Phase IV: long-running follow-up at scale, low-friction site burden.

DPDP Act 2023

Aligned by design

Schedule Y

CDSCO-aligned by design

ISO 27001

Information security controls aligned

Other ways teams use Trialion

Built-in PK sampling schedules, replicate-design support, and ANDA-ready exports — for the segment where India leads global study volume.

Short, focused trials at scale — pricing and tooling aligned to how generic-drug development actually operates in India.

Phase II to IV across therapeutic areas — same data model, configurable workflows, one continuous audit trail.